NCT03238339

Brief Summary

The subjects of this study are the chronic obstructive pulmonary disease (COPD) patients with chronic II respiratory failure. The participants will be divided into two groups: The Portable Home Noninvasive Ventilator treatment group and the routine home oxygen inhalation treatment group. All subjects will be given a stable COPD regimen and conventional oxygen therapy ,but the portable home noninvasive ventilator treatment group will need to wear a portable non-invasive ventilator. Objective evaluation indexes were established during the routine treatment, and two groups of subjects will be followed up for one year. Finally, the clinical data of all subjects will be analyzed,and then the practicability of portable wearable household noninvasive ventilator will be verified.The researchers will also build a remote breathing data-monitoring platform based on mobile internet,and a community home demonstration application point.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Sep 2017

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 31, 2017

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 3, 2017

Completed
1 month until next milestone

Study Start

First participant enrolled

September 15, 2017

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2020

Completed
Last Updated

December 23, 2019

Status Verified

December 1, 2019

Enrollment Period

3.3 years

First QC Date

July 31, 2017

Last Update Submit

December 20, 2019

Conditions

Keywords

Pulmonary Disease, Chronic ObstructiveRespiratory InsufficiencyOxygen Inhalation TherapyNoninvasive Ventilation

Outcome Measures

Primary Outcomes (1)

  • The frequency of the chronic obstructive pulmonary disease(COPD) acute exacerbation.

    Record the frequency of COPD acute exacerbation within one year

    one year

Secondary Outcomes (2)

  • The first onset time of the chronic obstructive pulmonary disease(COPD) acute exacerbation

    one year

  • The number of hospitalizations due to the chronic obstructive pulmonary disease(COPD) acute exacerbation

    one year

Other Outcomes (5)

  • Six Minute Walk Distance

    month0,month4,month8,month12

  • pulmonary arterial pressure

    month0,month4,month8,month12

  • arterial blood gas

    month0,month4,month8,month12

  • +2 more other outcomes

Study Arms (2)

The Portable Home Noninvasive Ventilator treatment group

The patients maintain a stable COPD regimen, and on the basis of conventional home oxygen therapy, a portable, wearable, non-invasive ventilator will be used.

Routine home oxygen therapy group

The patient maintained a stable COPD regimen and conventional home oxygen therapy.

Eligibility Criteria

Age40 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

The subjects were selected from the Department of respiration, Xinqiao Hospital of Chongqing city.

You may qualify if:

  • years old \< age \< 80 years old
  • COPD diagnosis was made according to GOLD guidelines
  • The subjects with chronic type II respiratory failure
  • The subjects with structural lung disease
  • The subjects signed informed consent.

You may not qualify if:

  • The subjects suffering from COPD acute exacerbation
  • The subjects currently participating in other related products
  • The subjects with organ dysfunction because of liver,kidney, hematopoietic system and serious metabolic disease endocrine system
  • The subjects with poor compliance
  • The subjects refused to sign the informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Emergency Department, Xinqiao Hospital, Third Military Medical University

Chongqing, China

RECRUITING

MeSH Terms

Conditions

Pulmonary Disease, Chronic ObstructiveRespiratory Insufficiency

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsRespiration Disorders

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
associate chief physician

Study Record Dates

First Submitted

July 31, 2017

First Posted

August 3, 2017

Study Start

September 15, 2017

Primary Completion

December 30, 2020

Study Completion

December 30, 2020

Last Updated

December 23, 2019

Record last verified: 2019-12

Locations